Clinical Trial Update: Safety and Efficacy Study of Encapsulated Human Islets Allotransplantation to Treat Type 1 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 safety and efficacy trial of encapsulated human islets allotransplantation for type 1 diabetes was withdrawn prior to completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Encapsulated human islets allotransplantation

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: WITHDRAWN